4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Coherus Oncology, Inc. (CHRS) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 145 employees. Its market capitalization is roughly $222 million. In the fiscal year ended 2025-12-31, CHRS reported $42M in revenue and $168M in net income.
Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.
Interactive charts & full statements → Open the CHRS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $42M | $26M | $257M | $211M | — |
| Gross Profit | $28M | $18M | $98M | $141M | — |
| Operating Income (EBIT) | ($181M) | ($200M) | ($203M) | ($257M) | — |
| Net Income | $168M | $28M | ($238M) | ($292M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $12M | $13M | $12M | $10M | $8M | — |
| Gross Profit | $8M | $9M | $8M | $7M | $5M | — |
| Operating Income (EBIT) | ($36M) | ($46M) | ($44M) | ($46M) | ($45M) | — |
| Net Income | ($38M) | ($38M) | ($36M) | $298M | ($57M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $258M | $448M | $630M | $481M | — |
| Total Liabilities | $197M | $580M | $823M | $618M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CHRS viewer.
About TickerBase · Data methodology & sources